Phreesia Faces Class Action Lawsuit from Investors
Written by Emily J. Thompson, Senior Investment Analyst
Updated: May 20 2026
0mins
Source: Globenewswire
- Lawsuit Background: Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Phreesia, alleging violations of federal securities laws from May 8, 2025, to March 30, 2026, seeking to recover losses for investors.
- Allegations Details: The complaint claims that Phreesia failed to disclose slowing demand and diminished visibility into key revenue streams during the class period, resulting in materially false and misleading statements about the company's business operations.
- Investor Actions: Affected investors have until July 13, 2026, to request to be appointed as lead plaintiff, with the law firm operating on a contingency fee basis, thereby minimizing financial risk for investors.
- Law Firm's Strength: Bronstein, Gewirtz & Grossman LLC is recognized for its success in recovering hundreds of millions for investors nationwide, emphasizing its expertise in securities fraud class actions and commitment to upholding market integrity.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 10.290
Low
24.00
Averages
29.09
High
35.00
Current: 10.290
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Faces Class Action Lawsuit from Investors
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Phreesia, seeking damages for investors who purchased securities between May 8, 2025, and March 30, 2026, highlighting significant investor dissatisfaction with the company's financial transparency.
- Allegations: The complaint alleges that Phreesia made materially false and misleading statements during the class period, failing to disclose slowing demand and diminished visibility into key revenue streams, which severely undermined investor confidence in the company's prospects.
- Market Impact: The lawsuit could exert downward pressure on Phreesia's stock price, potentially exacerbating losses for investors during this period, reflecting a pessimistic outlook on the company's future performance in the market.
- Investor Rights Protection: The law firm offers legal services on a contingency fee basis, meaning they will only charge fees if they successfully recover damages, ensuring minimal financial burden for investors seeking to assert their rights.
See More
Investigation into Phreesia, Inc. Shareholder Rights
- Shareholder Rights Investigation: Bernstein Liebhard LLP is investigating whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties, focusing on shares purchased prior to May 8, 2025, which could impact shareholder rights.
- Legal Consultation Opportunity: Shareholders holding Phreesia stock can discuss their legal rights and options by contacting Investor Relations Manager Peter Allocco, indicating potential legal risks facing the company.
- Reputable Law Firm: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for clients, showcasing its strong capabilities and reputation in investor rights protection, which may positively influence Phreesia shareholders.
- Litigation Success Record: The firm has been recognized multiple times on The National Law Journal’s “Plaintiffs’ Hot List” for successfully litigating hundreds of lawsuits and class actions, indicating its influence in the legal field and potentially attracting more shareholders to participate in the investigation.
See More
Reminder for Shareholder Class Action Lawsuits
- Lawsuit Overview: Holzer & Holzer LLC reminds investors of a class action lawsuit against Graphic Packaging Holding Company, alleging that from February 2025 to February 2026, the company failed to disclose critical inventory management information, potentially leading to investor losses.
- Deadline for Action: Investors must apply to be appointed lead plaintiff by July 6, 2026, to protect their legal rights, as failing to do so may result in the loss of their claims.
- Immutep Lawsuit: A similar class action against Immutep Limited alleges that from March 2025 to March 2026, the company did not disclose important information regarding the status and prospects of its TACTI-004 trial, with the same deadline for investors to act.
- Phreesia Lawsuit: The class action against Phreesia, Inc. involves misleading statements about its long-term growth outlook made between May 2025 and March 2026, with a deadline for lead plaintiff applications set for July 13, 2026.
See More
Phreesia Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Phreesia, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by July 13, 2026, indicating significant legal risks for the company.
- Revenue Guidance Cut: On March 30, 2026, Phreesia announced a substantial reduction in revenue growth projections for fiscal year 2027, attributing this shortfall to macroeconomic factors and weakened pharmaceutical marketing commitments within its Network Solutions segment, highlighting the challenges the company faces in the market.
- Stock Price Plummets: Following the revenue guidance cut, Phreesia's stock price fell by $3.03, or 26.56%, closing at $8.38 per share on March 31, 2026, reflecting investor concerns regarding the company's future outlook.
- Legal Background: Pomerantz LLP is a prominent law firm specializing in class action litigation in securities and antitrust, with a long history of recovering multimillion-dollar damages for victims, suggesting that this lawsuit could have lasting implications for Phreesia's reputation and financial health.
See More
Phreesia Faces Class Action Lawsuit Risk
- Class Action Notice: The Portnoy Law Firm advises Phreesia investors of a class action for those who purchased securities between May 8, 2025, and March 30, 2026, with a deadline for lead plaintiff motions set for July 13, 2026, indicating significant legal risks that could undermine shareholder confidence.
- Revenue Outlook Downgrade: On March 30, 2026, Phreesia lowered its fiscal year 2027 revenue guidance from $545 million-$559 million to $510 million-$520 million, reflecting reduced commitments from pharmaceutical clients and increased variability in revenue forecasting, which may jeopardize future financial performance.
- Severe Market Reaction: Following the revenue outlook downgrade, Phreesia's stock plummeted from $11.41 per share to $8.38 per share, a decline of approximately 27%, highlighting growing investor concerns regarding the company's future prospects and potential impacts on its market position.
- Legal Consultation Opportunity: The Portnoy Law Firm offers complimentary case evaluations and encourages investors to discuss legal options for recovering losses, demonstrating the firm's commitment to transparency and investor rights amidst ongoing legal challenges.
See More
Phreesia Class Action Lawsuit Notification
- Class Action Deadline: Rosen Law Firm reminds investors who purchased Phreesia (NYSE:PHR) common stock between May 8, 2025, and March 30, 2026, that they must apply to be lead plaintiff by July 13, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false and misleading statements during the class period, concealing material adverse facts about slowing demand and reduced visibility in key revenue streams, leading to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
Phreesia Faces Class Action Lawsuit from Investors
- Class Action Filed: Bronstein, Gewirtz & Grossman LLC has initiated a class action lawsuit against Phreesia, seeking damages for investors who purchased securities between May 8, 2025, and March 30, 2026, highlighting significant investor dissatisfaction with the company's financial transparency.
- Allegations: The complaint alleges that Phreesia made materially false and misleading statements during the class period, failing to disclose slowing demand and diminished visibility into key revenue streams, which severely undermined investor confidence in the company's prospects.
- Market Impact: The lawsuit could exert downward pressure on Phreesia's stock price, potentially exacerbating losses for investors during this period, reflecting a pessimistic outlook on the company's future performance in the market.
- Investor Rights Protection: The law firm offers legal services on a contingency fee basis, meaning they will only charge fees if they successfully recover damages, ensuring minimal financial burden for investors seeking to assert their rights.
See More
Investigation into Phreesia, Inc. Shareholder Rights
- Shareholder Rights Investigation: Bernstein Liebhard LLP is investigating whether certain directors and officers of Phreesia, Inc. breached their fiduciary duties, focusing on shares purchased prior to May 8, 2025, which could impact shareholder rights.
- Legal Consultation Opportunity: Shareholders holding Phreesia stock can discuss their legal rights and options by contacting Investor Relations Manager Peter Allocco, indicating potential legal risks facing the company.
- Reputable Law Firm: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for clients, showcasing its strong capabilities and reputation in investor rights protection, which may positively influence Phreesia shareholders.
- Litigation Success Record: The firm has been recognized multiple times on The National Law Journal’s “Plaintiffs’ Hot List” for successfully litigating hundreds of lawsuits and class actions, indicating its influence in the legal field and potentially attracting more shareholders to participate in the investigation.
See More
Reminder for Shareholder Class Action Lawsuits
- Lawsuit Overview: Holzer & Holzer LLC reminds investors of a class action lawsuit against Graphic Packaging Holding Company, alleging that from February 2025 to February 2026, the company failed to disclose critical inventory management information, potentially leading to investor losses.
- Deadline for Action: Investors must apply to be appointed lead plaintiff by July 6, 2026, to protect their legal rights, as failing to do so may result in the loss of their claims.
- Immutep Lawsuit: A similar class action against Immutep Limited alleges that from March 2025 to March 2026, the company did not disclose important information regarding the status and prospects of its TACTI-004 trial, with the same deadline for investors to act.
- Phreesia Lawsuit: The class action against Phreesia, Inc. involves misleading statements about its long-term growth outlook made between May 2025 and March 2026, with a deadline for lead plaintiff applications set for July 13, 2026.
See More
Phreesia Faces Class Action Lawsuit Impacting Stock Price
- Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Phreesia, alleging securities fraud and other unlawful business practices, with investors needing to apply as Lead Plaintiff by July 13, 2026, indicating significant legal risks for the company.
- Revenue Guidance Cut: On March 30, 2026, Phreesia announced a substantial reduction in revenue growth projections for fiscal year 2027, attributing this shortfall to macroeconomic factors and weakened pharmaceutical marketing commitments within its Network Solutions segment, highlighting the challenges the company faces in the market.
- Stock Price Plummets: Following the revenue guidance cut, Phreesia's stock price fell by $3.03, or 26.56%, closing at $8.38 per share on March 31, 2026, reflecting investor concerns regarding the company's future outlook.
- Legal Background: Pomerantz LLP is a prominent law firm specializing in class action litigation in securities and antitrust, with a long history of recovering multimillion-dollar damages for victims, suggesting that this lawsuit could have lasting implications for Phreesia's reputation and financial health.
See More
Phreesia Faces Class Action Lawsuit Risk
- Class Action Notice: The Portnoy Law Firm advises Phreesia investors of a class action for those who purchased securities between May 8, 2025, and March 30, 2026, with a deadline for lead plaintiff motions set for July 13, 2026, indicating significant legal risks that could undermine shareholder confidence.
- Revenue Outlook Downgrade: On March 30, 2026, Phreesia lowered its fiscal year 2027 revenue guidance from $545 million-$559 million to $510 million-$520 million, reflecting reduced commitments from pharmaceutical clients and increased variability in revenue forecasting, which may jeopardize future financial performance.
- Severe Market Reaction: Following the revenue outlook downgrade, Phreesia's stock plummeted from $11.41 per share to $8.38 per share, a decline of approximately 27%, highlighting growing investor concerns regarding the company's future prospects and potential impacts on its market position.
- Legal Consultation Opportunity: The Portnoy Law Firm offers complimentary case evaluations and encourages investors to discuss legal options for recovering losses, demonstrating the firm's commitment to transparency and investor rights amidst ongoing legal challenges.
See More
Phreesia Class Action Lawsuit Notification
- Class Action Deadline: Rosen Law Firm reminds investors who purchased Phreesia (NYSE:PHR) common stock between May 8, 2025, and March 30, 2026, that they must apply to be lead plaintiff by July 13, 2026, to participate in the class action and potentially receive compensation.
- Lawsuit Background: The lawsuit alleges that Phreesia made false and misleading statements during the class period, concealing material adverse facts about slowing demand and reduced visibility in key revenue streams, leading to investor losses when the truth emerged.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and has achieved the largest securities class action settlement against a Chinese company, being ranked No. 1 by ISS Securities Class Action Services in 2017, demonstrating its strong capabilities in this field.
- Investor Guidance: Investors are advised to carefully select law firms with proven success in leadership roles, avoiding firms that merely act as intermediaries, to ensure effective legal representation and support in the class action.
See More
